⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 22, 2021Journal of Clinical OncologyOpen Access

Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer

Lisa M. Jacola Marita Partanen Jurgen Lemiere Melissa M. Hudson Sophie Thomas

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

sponsorship: Support was provided by the NIH National Cancer Institute grants(s) (P30-CA21765 and GM92666 to St Jude Children's Research Hospital) and the American Lebanese Syrian Associated Charities (ALSAC). (NIH National Cancer Institute|P30-CA21765, NIH National Cancer Institute|GM92666, American Lebanese Syrian Associated Charities (ALSAC), National Cancer Institute|P30CA015704, National Cancer Institute|P30CA021765)

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jacola et al. (2021) studied this question.

synapsesocial.com/papers/6a7566061078cf7de2b21525 https://doi.org/10.1200/jco.20.02444

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology GroupJournal of Clinical Oncology · 2026
2Stereotactic Ablative Radiotherapy Versus Surgical Resection for Early-Stage Non–Small Lung Cancer: An Emulated Target TrialJournal of Clinical Oncology · 2026
3Immunochemotherapy for Borderline Resectable or Locally Advanced Pancreatic Cancer: A Randomized Controlled TrialJournal of Clinical Oncology · 2026
4Methylphenidate for Hematologic Cancer–Related Fatigue: A Randomized Clinical TrialJournal of Clinical Oncology · 2026
5Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4Journal of Clinical Oncology · 2026

KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non–Small Cell Lung CancerJournal of Clinical Oncology · 2026
Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 StudyJournal of Clinical Oncology · 2026
Art as a Shared Space: Tracing the Unseen Through a Body MapJournal of Clinical Oncology · 2026
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Living Guideline, Version 2026.1.0Journal of Clinical Oncology · 2026
Dalmelitinib Plus Aumolertinib in Advanced NSCLC Patients With EGFR-TKI Resistance and MET Amplification: A Randomized Phase 3 TrialJournal of Clinical Oncology · 2026

More from Journal of Clinical Oncology

More from St. Jude Children's Research Hospital

More from Princess Máxima Center